- Article
Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
- Paola Monciino,
- Lorenza Magagnoli,
- Eliana Fasulo,
- Michela Frittoli,
- Chiara Leotta,
- Hoang Nhat Pham,
- Andrea Stucchi,
- Paola Ciceri,
- Andrea Galassi and
- Mario Cozzolino
Background. Secondary hyperparathyroidism (SHPT) is a major risk factor for cardiovascular events and all-cause mortality in hemodialysis (HD) patients. The purpose of our study was to evaluate the effects and tolerability of etelcalcetide in HD pati...

